logo

News

Newspapers stacked
DNA underlay

News

adnas logo

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

May 15th, 2025

Read More

apdn circle logo

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

May 14th, 2025

Read More

synthetic dna

Applied DNA’s LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

April 21st, 2025

Read More

adnas logo

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

April 8th, 2025

Read More

Applied DNA Positions TR8 PGx Testing Service as Pre-emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

April 1st, 2025

Read More

Linea™ Avian Influenza H5 Dx assay

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

March 26th, 2025

Read More

Adnas icon

Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

March 12th, 2025

Read More

adnas logo

Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

February 13th, 2025

Read More

adnas logo

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

February 12th, 2025

Read More